3 underperforming FTSE 100 shares to buy today

These three FTSE 100 shares are recovering, but still lag the market. Here’s why I’d buy them while there’s still time.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Most FTSE 100 shares have been climbing in 2021. And there are some of those I’d still buy today. But what about the shares that have lagged the index this year?

They include Unilever (LSE: ULVR). Investors abandoned what they saw as risky shares last year and flocked to safer stocks like Unilever. As a result, the share price gained. But since the general stock market recovery kicked off in November, Unilever shares have fallen back.

From a high point last year, we’re looking at a 12% drop. That’s better than how things were looking in February though. At the end of that month, Unilever had lost almost 25% from its peak. I reckon it was a buy then, and I’d have had some myself had I not seen even better bargains.

Since a mini-recovery of the past few months, the shares are pretty much flat in 2021, compared to a 10% gain for the FTSE 100.

I see a risk that investors will continue to shun last year’s safe stocks, and Unilever could suffer a weak 2021. But I still see it a long-term buy, and it’s on my shortlist.

Top FTSE 100 dividend

Utilities stocks have performed poorly in 2021, though they’re starting to come back. I’m looking at National Grid (LSE: NG) right now, which fell quite hard in the first three months of the year. It’s been recovering, but the bigger picture shows weakness.

The National Grid share price is still down 10% since the stock market crash kicked off in mid-February last year. So it’s been lagging the FTSE 100 recovery, but does that make it a bargain?

National Grid has reported falling underlying earnings per share for a couple of years. But that should hopefully pick up again now, and I don’t see any long-term threat to the dividend. The 2021 dividend represents a 5.3% yield on the current National Grid share price — one of the FTSE 100’s best.

In these days of super-low interest rates, I see that as especially attractive. But it does suggest to me that the market values National Grid too lowly. Is that related to the hydrocarbon energy crisis? Though National Grid should still do fine however energy is generated, I do see some threat there.

We’re heading for an energy transition, and that could affect the entire delivery chain. Still, National Grid remains on my dividend buy list.

Falling pharma

My third choice is GlaxoSmithKline (LSE: GSK). And it does seem strange for a pharmaceuticals company to be underperforming in the pandemic. Maybe it’s because its name isn’t associated with a Covid vaccine, unlike Footsie competitor AstraZeneca?

Whatever the reason, Glaxo shares are down 14% since the crash started. And though they’ve picked up in the past few months, they still lag the FTSE 100 in 2021.

But is GlaxoSmithKline a buy now? Firstly, a lot of investors have approached the pharma business very differently in the past couple of years. That’s not surprising, with the prospect of big short-term gains from coronavirus research hovering in front of us. But I have to remind myself that pharmaceuticals is a long-term business.

And with a long-term horizon, I have Glaxo down as one to buy on the dips.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline, National Grid, and Unilever. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Could Premier African Minerals be a millionaire-maker penny stock?

Shares of Premier African Minerals (LSE:PREM) have crashed over the past year. Is this a golden opportunity for me to…

Read more »

British flag, Big Ben, Houses of Parliament and British flag composition
Investing Articles

Which FTSE defence stock should I buy? Here’s what the charts say

FTSE shares like BAE Systems have been flying higher over the last couple of years as the geopolitical situation has…

Read more »

Shot of a senior man drinking coffee and looking thoughtfully out of a window
Investing Articles

Here’s why investors should consider buying Scottish Mortgage shares today

After a steady rise in recent times, this Fool thinks Scottish Mortgage shares could be worth considering. Here he explains…

Read more »

Young black man looking at phone while on the London Overground
Growth Shares

This FTSE 250 stock keeps blowing broker forecasts out of the water

Jon Smith considers the ever-increasing share price targets for a FTSE 250 stock that has risen by 120% in the…

Read more »

A mixed ethnicity couple shopping for food in a supermarket
Investing Articles

Marks and Spencer shares could rise 29%, according to this broker

Marks and Spencer shares currently sport a P/E ratio of just 10, and one well-known City broker believes the company…

Read more »

Smart young brown businesswoman working from home on a laptop
Investing Articles

2 of the best FTSE 100 beginner stocks to consider buying

The Footsie offers people just beginning their investment journey some of the best stocks to buy. Here are two to…

Read more »

Middle-aged white man wearing glasses, staring into space over the top of his laptop in a coffee shop
Investing Articles

Here’s why the Aviva share price suddenly dived

The Aviva share price suddenly dropped by over 6% the other day. But there's a simple explanation for this sudden…

Read more »

Long-term vs short-term investing concept on a staircase
Investing Articles

With no savings, I’d listen to Warren Buffett to aim for long-term wealth

Warren Buffett looks for "1-foot bars" to step over, not "7-foot bars" to jump. Stephen Wright looks at what this…

Read more »